What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Pramod K. Srivastava mainly focuses on Heat shock protein, Immunology, Cell biology, Antigen and Antigen presentation.
His Heat shock protein research includes themes of Molecular biology and Cytotoxic T cell, Antigen-presenting cell.
His biological study spans a wide range of topics, including Receptor, In vivo, Immunity and CD40.
Pramod K. Srivastava combines subjects such as Cancer research and Virology with his study of Antigen.
His work deals with themes such as MHC class I, Major histocompatibility complex and HSP60, which intersect with Antigen presentation.
The Hsp70 study combines topics in areas such as Hsp90 and Peptide.
His most cited work include:
- Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway (1173 citations)
- CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. (997 citations)
- Roles of heat-shock proteins in innate and adaptive immunity. (871 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Heat shock protein, Immunology, Antigen, Immune system and Biochemistry.
His research integrates issues of Molecular biology, Antigen presentation, Peptide and Cell biology in his study of Heat shock protein.
He frequently studies issues relating to Receptor and Cell biology.
His work is dedicated to discovering how Immunology, Cancer are connected with Oncology and other disciplines.
Pramod K. Srivastava regularly links together related areas like Antigen-presenting cell in his Antigen studies.
Particularly relevant to Acquired immune system is his body of work in Immune system.
He most often published in these fields:
- Heat shock protein (23.06%)
- Immunology (22.86%)
- Antigen (20.82%)
What were the highlights of his more recent work (between 2013-2021)?
- Antigen (20.82%)
- Immunogenicity (6.73%)
- Immune system (18.37%)
In recent papers he was focusing on the following fields of study:
Pramod K. Srivastava spends much of his time researching Antigen, Immunogenicity, Immune system, Epitope and Water content.
His Antigen study incorporates themes from Antigen presentation and Immunotherapy.
Pramod K. Srivastava focuses mostly in the field of Immunogenicity, narrowing it down to matters related to Molecular biology and, in some cases, Tumor rejection and Virology.
His Immune system study combines topics in areas such as Cancer and Cell biology.
His research integrates issues of Cause of death, Immunology and Oncology in his study of Cancer.
He has included themes like Ovalbumin and MHC class I, CD8, Major histocompatibility complex in his Epitope study.
Between 2013 and 2021, his most popular works were:
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. (468 citations)
- Classification of current anticancer immunotherapies (249 citations)
- Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity (216 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Immunology, Antigen, Immune system, Immunotherapy and Computational biology.
His Immunology study combines topics from a wide range of disciplines, such as Cancer, Cytotoxic T cell and Rheumatology.
His research in Antigen intersects with topics in Cell biology and Antigen-presenting cell.
He has researched Cell biology in several fields, including Heat shock protein, CD11c, Endocannabinoid system and Depolarization-induced suppression of inhibition, Cannabinoid receptor.
His Immune system research incorporates themes from Tumor size, Area under the curve, Receptor, Cannabinoid and Cannabinoid receptor type 2.
His studies examine the connections between Antigen presentation and genetics, as well as such issues in Epitope, with regards to CD8.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
